What does BioXcel Therapeutics, Inc. do?

Jun 22 2025 07:00 PM IST
share
Share Via
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing drugs for psychiatric disorders and rare cancers. As of March 2025, it has a market cap of $9.93 million, with net sales of $0 million and a net profit of -$7 million.
Overview:
BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing drugs for psychiatric disorders and rare cancers, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -7 Million (Quarterly Results - Mar 2025)
Market-cap: USD 9.93 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.83
Return on Equity: 39.44%
Price to Book: -0.11

Contact Details:
Address: 555 Long Wharf Dr, NEW HAVEN CT: 06511-6107
Tel: ['1 203 6438060', '1 646 3782942']
Fax: 1 302 6365454
Website: http://www.bioxceltherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is BioXcel Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:36 PM IST
share
Share Via
Is BioXcel Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:17 AM IST
share
Share Via
How big is BioXcel Therapeutics, Inc.?
Jun 22 2025 06:13 PM IST
share
Share Via